CD4 and neoplasm: Hence, we analyzed the splenocytes isolated from rNDV-treated tumor-bearing mice, and found that the percentage of CD4+ T and CD8+ T cells in rNDV-IL2-NP/P treated group were much higher than other rNDV-treated groups.